Publications of the Week: Psilocybin for major depressive disorder: Is there magic in this treatment?
A digest of noteworthy publications from McMaster experts. This week’s focus: psilocybin for major depressive disorder.
A digest of noteworthy publications from McMaster experts. This week’s focus: psilocybin for major depressive disorder.
A digest of noteworthy publications from McMaster experts. This week’s focus: ketamine in treatment-resistant depression.
A digest of noteworthy publications from McMaster experts. This week’s focus: efficacy of donanemab in early symptomatic Alzheimer disease.
A digest of noteworthy publications from McMaster experts. This week’s focus: effects of early versus late initiation of anticoagulation in patients with atrial fibrillation and stroke.
A digest of noteworthy publications from McMaster experts. This week’s focus: perioperative management of long-term antihypertensive medications in patients undergoing noncardiac surgery.
A digest of noteworthy publications from McMaster experts. This week’s focus: effects of the addition of hydrocortisone to usual care on mortality in severe community-acquired pneumonia (CAP).
A digest of noteworthy publications from McMaster experts. This week’s focus: thromboprophylaxis in patients with fractures.
A digest of noteworthy publications from McMaster experts. This week’s focus: medical masks and N95 respirators in the setting of COVID-19.
A digest of noteworthy publications from McMaster experts. This week’s focus: estimated global proportions of individuals with long COVID.
A digest of noteworthy publications from McMaster experts: olokizumab versus placebo or adalimumab in RA.